The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For example, 10 years ago in Ethiopia and Kenya, cancer care was available to only a few thousand patients per year in a few hospitals. Today, over 75,000 people receive cancer treatment each year in each of these countries.
Over 800,000 people on the continent are diagnosed with this disease each year.
But medicine regulatory agencies in many countries don’t have the capacity to measure the quality of anticancer drugs. This is particularly problematic for two reasons. Firstly, the high cost of the drugs is an incentive to opt for unverified ones. And secondly, they are highly toxic.
